Medical Information Systems: A Foundation for Healthcare Technologies in Developing Countries by Hall-Clifford, Rachel et al.
 
Medical Information Systems: A Foundation for Healthcare
Technologies in Developing Countries
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Clifford, Gari D., Joaquin A. Blaya, Rachel Hall-Clifford, and
Hamish S.F. Fraser. 2008. Medical information systems: A
foundation for healthcare technologies in developing countries.
BioMedical Engineering OnLine 7: 18.
Published Version doi:10.1186/1475-925X-7-18
Accessed February 19, 2015 8:15:20 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:4774050
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAABioMed  Central
Page 1 of 8
(page number not for citation purposes)
BioMedical Engineering OnLine
Open Access Editorial
Medical information systems: A foundation for healthcare 
technologies in developing countries
Gari D Clifford*1,2, Joaquin A Blaya2,3, Rachel Hall-Clifford4 and 
Hamish SF Fraser3,5
Address: 1Massachusetts Institute of Technology, Cambridge, MA, USA, 2Harvard-MIT Division of Health Sciences & Technology, Cambridge, MA, 
USA, 3Partners In Health, Boston, MA, USA, 4Department of Anthropology, Boston University, Boston, MA, USA and 5Division of Social Medicine 
and Health Inequalities, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
Email: Gari D Clifford* - gari@mit.edu; Joaquin A Blaya - jblaya@hms.harvard.edu; Rachel Hall-Clifford - rahall@bu.edu; 
Hamish SF Fraser - hamish_fraser@hms.harvard.edu
* Corresponding author    
Background
Economic disadvantages in developing countries have
resulted in health care per capita spending that is almost
two orders of magnitude lower than in developed coun-
tries [1]. In addition, tertiary-care hospitals in developing
countries typically consume a large proportion of overall
health care spending, and less than a quarter of govern-
ment spending is devoted to public health measures and
clinical care in primary care settings [2,3]. Community-
based care has the capacity for further reaching impact
and has been shown to be effective in treatment and mon-
itoring of HIV (Human Immunodeficiency Virus), tuber-
culosis (TB), and maternal health in resource-poor
settings [4-7]. Reliance on community-based care is likely
to become even more important as large-scale, chronic
disease management is required for HIV and tuberculosis
care in settings where acute care or no care at all, is the
norm.
In most developing countries, aside from the wealthiest
urban areas, the health infrastructure is currently ill-
equipped to meet this increasing demand. Although vari-
ous technologies have been proposed as elements in the
solution of this crisis, it is still unclear which technologies
have the highest on-the-ground impact and to which set-
tings they are best suited. More extensive data collection
concerning medical needs is required to enable the accu-
rate assessment of the effectiveness of interventions and
current health care practices.
In 2004, global health spending reached a total of US$ 4.1
trillion. Ninety percent of this total was spent by the 30
wealthy countries of the Organization for Economic Co-
operation and Development (OECD), which make up
20% of the world's population [8]. On average, OECD
countries spent more than 11% of their gross domestic
product on health, while the countries of the World
Health Organization's (WHO) African and South-East
Asia regions spent 4.7% [8]. In absolute terms, low-
income countries spent US$ 32 per capita on health care
in 2004, and high-income countries spent US$ 3,724 per
capita. Low-income countries health expenditures fall far
short of the US$ 60 per capita that the WHO posits is nec-
essary for an adequately functioning health system [9].
Developing countries, like developed countries, face diffi-
cult decisions in distributing limited health-care
resources. However, this large health care funding gap
makes it even more important that low-income countries
have optimal resource distribution.
Poverty itself is one of the principal causes of illness in
developing countries, and disease in some low-income
regions is a significant barrier to economic growth. Poor
health causes a spiral of loss of income and is an inhibitor
to education [10], which is itself a barrier to obtaining
good health (and making good health decisions).
Research commissioned by the WHO found that the eco-
nomic impact of ill health on individuals and societies is
far greater than previously estimated [11]. However, they
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also go on to state that providing basic health care to the
world's poor is both technically feasible and cost effective,
potentially saving million lives annually and fuelling
development by generating hundreds of billions of dol-
lars in new economic activity every year.
As Saxenian points out tertiary-care hospitals in develop-
ing countries, alone may consume 30% to 50% percent of
overstretched health budgets [2] (although they generally
provide the most specialized and sophisticated services
and most clinical research, education, and training). Only
a quarter of government spending, and often less, is
devoted to cost-effective public health measures and to
clinical care that is delivered in local health centers and
other community settings. This misallocation means that
large subgroups in the population, particularly the rural
poor, have extremely limited access to health services.
Limited government money means that some primary
care level treatments are free but more extensive treat-
ment/care can be very costly and cause households to fall
into poverty [9]. The World Bank has stressed the value of
the primary health care interventions that are commonly
included in programs to reduce childhood malnutrition
and mortality, chiefly from infectious diseases. However,
several of these highly cost-effective interventions have
largely been neglected, including: chemotherapy against
tuberculosis; integrated prenatal and delivery care; mass
programs to de-worm children; and provision of con-
doms along with information and education to combat
AIDS [9].
A recent report by the WHO projects that, over the next
twenty years, HIV/AIDS will account for the greatest bur-
den of disease world-wide, followed by depression and
ischemic heart disease. Smoking-related illnesses and
HIV/AIDS will be the leading causes of death [12]. How-
ever, Mathers also points out that this is based upon the
assumption that future mortality and risk factor trends in
poor countries will have the same relationship to eco-
nomic and social development as has occurred in the
higher income countries over the last 50 years. If this
assumption is wrong, then predictions may be worse.
Therefore, in order to best allocate resources, tracking of
health care problems and the evaluation of prevention
and treatment programs (particularly where HIV/AIDS is
concerned) as a function of local economics and social
attitudes is essential. Information technology has been
proposed as an efficient method for improving the effec-
tiveness and efficiency of health care [13], and has been
shown to be particularly useful in the context of outcome
improvement, cost reduction [14] and disease interven-
tion [15-20]. This article therefore concentrates, not on
what health care programs and devices are likely to be use-
ful, but on how information technology can be employed
to improve our understanding of what technologies and
practices are needed, while addressing specific problems,
such as information loss (and errors), long latencies in
delivery, and the cost of health care provision.
Tracking Health Care, Databases and 
Information Systems
Information technology and electronic medical records
(EMRs) have been shown to provide significant benefits
in developed countries. Studies have shown that it can
improve patient outcomes in the management of renal
disease [14,21]. In another recent study of almost a mil-
lion patients in the Colorado and Northwest regions of
the Kaiser Permanente health care system, two years after
electronic health records were fully implemented, age
adjusted rates of office visits were shown to be 9% lower
in both regions [22]. Age adjusted primary care visits were
shown to drop by 11% in both regions and specialty care
visits decreased by 5% in Colorado and 6% in the North-
west. All decreases were significant (P < 0.0001). Wang et
al. [23] have estimated that the net benefit from using an
electronic medical record for a 5-year period was $86,400
US per provider. Benefits accrue primarily from savings in
drug expenditures, improved utilization of radiology
studies, better capture of charges, and decreased billing
errors. A recent long term study of the US Veterans Health
Administration (VHA) has demonstrated that EMRs
improve efficiency by an estimated 6% per year, and that
the only a small number of unnecessary tests or admis-
sions resulted from the usage of their EMR [24].
Although large differences exist between infrastructure
and resources for health care in developing countries [25-
27], it is possible that EMRs are able to provide similar
impacts on health care in developing countries. In fact,
given the poor state of medical record keeping in many
developing regions, EMRs may even lead to much larger
impacts on outcomes, health care efficiency and treatment
delivery in developing countries [28-31].
In 2005, Eiseman and Fossum pointed out that available
health resource data for developing countries is currently
a "patchwork of information at different levels of aggrega-
tion and resolution and of varying quality and timeliness
that falls short in meeting the needs of the many diverse
objectives and organizations that require such data" [32].
Furthermore, "many current data collections rely on
labor-intensive collection techniques that require exten-
sive planning and the skills of specially trained teams,
which can prove burdensome to those providing the data
and may be detrimental to the data's accuracy and timeli-
ness". Eiseman and Fossum and others go on to point out
that existing data collections are insufficiently compre-
hensive, sometimes inaccurate, and often out of date by
the time the data can be acted upon [32] ([33]. Without
such data, none of the parties trying to address the healthBioMedical Engineering OnLine 2008, 7:18 http://www.biomedical-engineering-online.com/content/7/1/18
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problems of developing countries has the required empir-
ical knowledge to inform policy decisions about health
resource mobilization and allocation, strategic planning,
priority setting, monitoring and evaluation, advocacy,
and general policymaking [34-36].
Eiseman and Fossum propose that any global health
resource tracking system would contain valid, detailed
data (who, what, where, how much) on all health
resources (cash and in-kind) provided in previous, current
and the next fiscal years to all developing countries by all
public and private entities. Furthermore, this should be
provided in (almost) real time, without double-counting
any resources. Such a system should also have the follow-
ing ideal properties:
1. Impose on any public or private entity no more than a
minimal burden in terms of its provision of the informa-
tion needed to populate the system.
2. Readily harmonize with and connect to the existing
data systems of receiving countries and all donor entities.
3. Be easily accessible via the Web and flexibly searchable
by every data element in a variety of languages.
4. Enjoy broad ownership, official buy-in, and use, with
long-term support from a diversified funding base.
Eiseman and Fossum point out that this would require
that practical data systems already exist in a meaningful
way and that they are easily accessible to the relevant
users. The reality is that most countries do not use digital
health records, and even those who do, often have an
extremely limited ability to facilitate searches and
exchange data with other systems [37,38]. Furthermore,
there is no clear consensus on how the data should be col-
lected, and in what format should the data be stored.
These are two key issues in the development of a useful
medical health record.
Essentially, there are two possible approaches to the stor-
age of data in an EMR. The first prescribes a top-down
national (or international) schema for the medical data,
such as the GEHR/openEHR standard, the CEN EN 13606
EHRcom standard, and the HL7 standard. (See Sanroma et
al. [39] for a good overview of these standards.) The major
disadvantages of these approaches are that they are diffi-
cult to implement for small projects and are not always
suited to primary care-level information collection. An
alternative approach is to employ a system that is built
from the bottom-up, such as OpenMRS [40-45]. These
approaches lead to a streamlined system that provides
only for the needs of the project, with little overhead.
However, the system is also standardized (for integration
with other software, and databases) and extensible so that
other data can easily be added to the system.
In both approaches, the EMR should be built with open-
source software. This has several advantages over closed
proprietary systems. Firstly, the system is more 'future-
proof', being able to withstand the changes in libraries,
operating systems and hardware. This avoids the prob-
lems of having to reverse-engineer data structures and
recode interfaces. Furthermore, software can be written in
a cross-platform manner, providing maximum choice and
flexibility for users. Secondly, open-source software is
license free and allows everyone to benefit from any devel-
opments made by others, minimizing the costs to every-
one involved. Vital funds can then be spent on the
support and augmentation of the code base. Use of open-
source software can also lead to an increase in competi-
tion and allow developing countries to support their own
software and applications and the development of related
businesses. Examples of such competition stimulation
can be seen in the adoption of Linux and Apache by the
Apple Corporation. Furthermore, open-source licensing
can allow small and medium-sized companies to build a
business around the support of medical databases. It
should be noted that open-source does not always mean
that software is always supplied at no-cost to the user, and
such software can be linked to proprietary libraries if the
source-code base is distributed under an appropriate
license, such as the modified BSD or LGPL licenses.
Thirdly, it is generally easier to detect and fix bugs in
open-source software, and compliance with standards is
more easily enforced. In particular, standards concerning
security and protected health information are more easily
audited when a system is open.
Since electronic data flow must involve hardware at some
point, hardware communication issues must also be con-
sidered. The problems of integrating hardware with pro-
prietary interfaces and back-end databases are well-known
in the developed world, and these issues do not benefit
either the patient or the health care system. That is not to
say that private enterprise's role in healthcare in develop-
ing countries is unimportant (and we leave this involved
discussion for another time), but the foundations of
device communication should be sufficiently open in
order to maximize the usefulness of any medical record
system.
In any EMR, it is also advantageous to include standard-
ized medical languages (such as the Unified Medical Lan-
guage System; UMLS), which have multiple-language
translations, enable multi-lingual versions of the elec-
tronic health record and help aggregate data across
regions and nations. Errors due to regional differences in
the names of drugs, or colloquial terminology for proce-BioMedical Engineering OnLine 2008, 7:18 http://www.biomedical-engineering-online.com/content/7/1/18
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dures can lead missed opportunities to treat or even to
serious medical errors.
Successful technology implementation requires 
multi-factorial approach
Unlike in developed countries where technology imple-
mentation can be focused and rely on existing infrastruc-
ture, in developing countries a multi-factorial approach is
necessary if technology is going to be implemented and
maintained successfully. Among some of the factors that
must be taken into account are, corruption, inequalities
within the country, imposition of sub-optimal policies or
technologies by authorities, and the lack of or incorrect
information. Corruption plagues health systems in all
countries. In developing countries, one common form is
the requisite informal payments to underpaid health staff
which creates a significant barrier to care [9]. A 2003 study
of the government health system in Albania found that
treatment was withheld in the absence of an informal pay-
ment and that patients included the estimated costs of
informal payments in their decisions to seek care [46,47].
A conceivable offshoot of this established corruption in
light of improved health care technology would be the
misuse of technology resources or the increase of existing
informal payments for their use. In establishing technol-
ogy-focused health programs in developing countries,
monitoring of users as well as data collection and entry
must be a significant concern, beginning in the planning
stages of program implementation.
In conceptualizing technology-based improvements to
health care in the developing world, it is essential to bear
in mind the disparities of access and quality of care that
currently exist within the health system in any given coun-
try and how the planned improvements may exacerbate
those inequities. If technological improvements are cen-
tered on urban areas, they will likely not impact the health
status of the rural poor and, thus, may only marginally
benefit the country's overall health indicators [48]. On an
implementation level, the strata of the health care hierar-
chy at which technological advancements will be made
are important to consider on the front-end, as this will
impact the needed hardware and user-interface. Further,
in targeting the end-user population early in the develop-
ment phases of a technology-based intervention, the
health care staff, be they doctors, nurses, or community
health workers, can be made a central part of the planning
and implementation teams. If the end-users do not per-
ceive a need or value to a new piece of technology, the
overall success of implementing that technology will
likely be low.
As Malkin [25-27] points out, problems such as rising
costs of medical equipment, embedded service contracts,
lack of spare parts, lack of required consumables, lack of
reliable power and water, lack of public infrastructure
such as roads, and lack of technical expertise, plague
health care technology in the developing world. While
poor infrastructure, such as the telecommunications and
electricity grid, should not be seen as justification for rel-
egating improvements in health care technology to the
future, the realities of existing capacities must be taken
into account. For example, many developing countries
have far more reliable wireless than traditional telecom-
munications systems [49], and technological advance-
ments should focus on those existing strengths.
Information and communications technology (ICT) is
one area in which developing countries have made signif-
icant advancements, and it has been touted as a cost-effec-
tive mechanism for delivering health care information in
developing countries [50]. In particular, ICT can be lever-
aged to address the dearth of trained personnel, by both
interpreting medical data and facilitating training. With a
continually growing rate of over 80% of the world's pop-
ulation living in range of a cellphone tower, telemedicine
applications for automated or remote analysis (such as X-
ray reading [51]) are becoming increasingly attractive.
In order to illustrate the above points, examples of suc-
cessful applications of ICT to health care for under-served
populations in Peru and Haiti are described in the follow-
ing section.
The PIH Projects in Peru and Haiti: Health ICT 
examples in middle and low income countries
In 1996 Partners In Health (PIH), with their Peruvian sis-
ter organization, Socios En Salud (SES) and the Peruvian
Ministry of Health, started a community-based treatment
program for drug-resistant tuberculosis in the slums of
Lima, Peru. Multi-drug resistant tuberculosis (MDR-TB) is
defined as TB resistant to isoniazid and rifampin, the two
most efficacious anti-tuberculous drugs. At that time the
few models for treatment of MDR-TB were costly and were
centered around referral hospitals. Reported rates of suc-
cess in middle-income countries and regions ranged from
less than 60% in Indonesia and Taiwan [52,53] to just
over 80% in Hong Kong, Korea, and Turkey [54-57]. PIH
and SES created a community-based project to treat MDR-
TB in a resource-poor setting. This new project termed
"DOTS-Plus" project built on top of the well-established
Peruvian Directly Observed Therapy-Short Course
(DOTS) program and treated patients with long-standing
disease due to highly resistant strains of TB.
Reported cure rates in this community-based, ambulatory
program were as high as any reported in a hospital setting
to date [7]. Unlike other cohorts, which had high default
rates, all patients in the PIH/SES cohort received directly
observed therapy. Adverse effects, moreover, were care-
fully managed to ensure completion of treatment. MitnickBioMedical Engineering OnLine 2008, 7:18 http://www.biomedical-engineering-online.com/content/7/1/18
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et al. [7] state that in 1997 "mean treatment costs were
US$15,681 per patient, these costs were low at that time –
approximately 10% of the costs for hospitalized patients
[58,59] – but well beyond the reach of most national
tuberculosis programs." Since then advocacy work and
pooled procurement have made second-line anti-tubercu-
lous drugs available to countries and programs needing
them. Through negotiations with the research-based and
generic pharmaceutical industries, the cost of drugs for
multi-drug-resistant TB was reduced by up to 98% [60]. By
establishing a long-term collaboration and moving treat-
ment into the community, PIH was able to provide high-
quality care, lower costs, reduce the risk of nosocomial
spread of MDR-TB [61-64], and provide additional, indi-
vidualized services that patients in low-resource areas may
need. Further, this community-based network can be
strengthened to provide primary care [65] and be a source
of data for further interventions.
The Partners In Health Electronic Medical Record (PIH-
EMR) [17], implemented in 2001, was developed to sup-
port the two-year MDR-TB treatment regimen for the
cohort described above. The PIH-EMR is an example of a
web-based EMR based on open-source technology and
backed by an Oracle database. The system is viewable in
both English and Spanish and currently has over 29,000
patients, 7,600 of which have received treatment. The
PIH-EMR includes a clinical record with initial history,
physical examination, laboratory results and medications
on all patients receiving individualized treatment for
MDR-TB. The custom medication order entry system pro-
vides advice on potential problems and feedback to the
clinical personnel. There is an extensive suite of web-
based analysis tools for reporting and outcome monitor-
ing [17]. Analysis tools are used to assess drug require-
ments based on the medications prescribed and perform
operation research. It is also linked to a pharmacy inven-
tory and dispensing system. Evaluations of modules of
this system have shown that the medication order entry
system produced significantly fewer errors than the previ-
ous paper and spreadsheet approach [15]. Drug usage pre-
diction tools have been shown to match the usage data in
the pharmacy to within 3% [16] and are used routinely is
drug ordering. Further modules have been added to the
PIH-EMR to collect and communicate TB laboratory data.
A personal digital assistant (PDA)-based system to collect
TB lab data from laboratories and health centers without
internet was shown to reduce processing delays from 30 to
8 days, reduce errors by 60%, and to be preferred by users
[66].
The PIH-EMR has recently been adopted by the Peruvian
National Tuberculosis Program for its drug-resistant TB
treatment program, and there are plans to expand its use
to the entire TB program in Peru. The PIH-EMR is also
used to create monthly reports for the Global Fund and
the Health Ministry. This experience demonstrates that
these types of systems are feasible to implement in
resource-poor settings. Another web-based module
termed e-Chasqui has been designed and implemented to
improve the timeliness and quality of laboratory data
[28]. In Peru, the e-Chasqui system has been deployed in
the national TB laboratory, two regional laboratories, and
24 pilot health centers. Since its full implementation in
March 2006, over 70,000 TB laboratory tests have been
entered into the system with over 99% of them viewed
online by the health centers. In total, e-Chasqui serves a
network of institutions providing medical care for over
3.1 million people at a cost of approximately US$0.53 per
sample, the annual total cost is equivalent to 1% of the
National Peruvian TB program's 2006 budget.
Since 1999, PIH has run a community-based HIV treat-
ment program in Haiti with its sister organization, Zanmi
Lasante, expanding to nine public health clinics in an area
with virtually no roads, electricity or telephone service. In
these clinics, 'Directly Observed Therapy with Highly
Active Antiretroviral Therapy' (DOT-HAART) for HIV is
modeled on successful tuberculosis control efforts like the
one described previously. Each HIV patient has a commu-
nity-health worker who observes ingestion of pills,
responds to patient and family concerns, and offers moral
support. Social support – including assistance with chil-
dren's school fees – is included in services offered.
Monthly meetings, in which patients discuss their illness
and other concerns, are notable for high attendance
[4,67]. In 2006 over 8,000 HIV-positive persons, 2,300 of
whom are on antiretroviral therapy (ART), are now fol-
lowed [68]. Adherence to HAART was very high, and clin-
ical outcomes were excellent: all patients responded with
weight gain and improved functional capacity, and fewer
than 5% required medication changes due to side effects
[69]. As elsewhere, patients receiving HAART are far less
likely to require admission to hospital than are patients
with untreated HIV disease [70].
The HIV-EMR, an open source web-based system [71],
was based on the PIH-EMR. Satellite-based internet access
at each site provides access to the system; however, due to
the inconsistent power and internet available, an addi-
tional offline client for data entry and review was imple-
mented [72]. The HIV-EMR system has been implemented
in all sites and currently has over 12,000 patients; 3,051
of which are receiving ART. The system records clinical
data including history, physical examination, social cir-
cumstances and treatment prescribed. Decision support
tools provide allergy and drug interaction warnings and
generate warning emails about low CD4 counts. (The
lower your CD4 count, the greater the chances of poten-
tially fatal infections.) Staff also keep paper records, butBioMedical Engineering OnLine 2008, 7:18 http://www.biomedical-engineering-online.com/content/7/1/18
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they can use the EMR to check for up to date lab results
and drug regimen data and monitor patients' follow-up
status. A suite of reporting tools allow staff to create key
reports, such as for the U.S. President's Emergency Plan
for AIDS Relief (PEPFAR), and automatically generate the
reports monthly. Data quality is backed by a monthly
checklist of patients and their drug regimens and treat-
ment status that is filled out by the pharmacy and nursing
staff and used to update and cross-check the EMR. There is
also a full pharmacy inventory system and tools for drug
regimen analysis. The inventory system allows pharmacy
staff at all clinics to enter stock levels and request drugs
and track shipments. This system is used to track 450
products supporting care for 1.78 million patient visits
annually. Over the last year drug stockouts have fallen
from 2.6% to 1.1% and 97% of stock requests delivered
were shipped within 1 day [73]. EMR systems have been
shown to provide a better one-year estimate for medica-
tion ordering and therefore reduce costs in having stock-
outs or more expensive, local emergency purchases com-
pared to the current method of ordering based on the last
year's estimates [74,75].
Summary
Among the significant barriers to the provision of health
care in developing countries, detailed information con-
cerning disease incidence, health practices and available
resources (such as drugs for treatment) are some of the
most important. Without detailed information concern-
ing the response to health programs, it is impossible to
evaluate the efficacy of a particular program and, hence,
effectively allocate funding and resources. Although
paper-based systems can provide a partial solution, infor-
mation transmission is slow and prone to errors. Further-
more, aggregation of data is challenging as patient
numbers rise into the hundreds [19], and near impossible
with thousands of patients. It is also difficult to impose
consistent reporting indicators.
The systems described above illustrate the advantages of
implementing healthcare technologies within larger col-
laborations that improve the overall public health infra-
structure. One key aspect of the technologies employed in
these projects is the use of open standards and open-
source development in a collaborative environment.
The cases described in this article also demonstrate the
need for community data collection, and feasibility of
using ICT to enable data collection, and improve informa-
tion flow in developing countries. Without such
approaches, interventions may exacerbate inequalities
within countries with weak infrastructure and ingrained
social disparities. However, these systems will only work
well with carefully designed forms and interfaces, and
excellent data management. Furthermore, EMRs can pro-
vide a foundational technology that allows for the adop-
tion and evaluation of other health care technologies,
such as drug ordering, medical devices, and longitudinal
patient follow-ups. Moreover, the projects described
above illustrate that the creation of long-term relation-
ships to build infrastructure and solving systemic prob-
lems to provide health care can be beneficial to both the
patients and the projects involved.
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